HomeAI · summaries
Storia in 4 fonti
Ozempic y Mounjaro podrían ralentizar la progresión de algunos cánceres, según estudios
Investigaciones exploran si el uso de fármacos GLP-1, contra obesidad y diabetes, benefician a pacientes con ciertos tipos de cáncer.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
nbcnews.com
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.
- ·
independent.co.uk
GLP-1 drugs may result in better outcomes for cancer patients, study claims
GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers
